UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001400
Receipt number R000001701
Scientific Title Comparison of maximal sterile barrier precautions with standard sterile barrier precautions on catheter-related blood stream infection: a multi-institutional randomized controlled trial.
Date of disclosure of the study information 2008/09/27
Last modified on 2015/04/06 12:28:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of maximal sterile barrier precautions with standard sterile barrier precautions on catheter-related blood stream infection: a multi-institutional randomized controlled trial.

Acronym

maximal precaution trial

Scientific Title

Comparison of maximal sterile barrier precautions with standard sterile barrier precautions on catheter-related blood stream infection: a multi-institutional randomized controlled trial.

Scientific Title:Acronym

maximal precaution trial

Region

Japan


Condition

Condition

Patients who were admitted in the general surgical wards and were planned to be inserted non-tunneled CVC.

Classification by specialty

Surgery in general

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether institution of maximal sterile barrier precautions (MSBP) during central venous catheter (CVC) insertion prevents catheter-related blood stream infection comparing to standard sterile barrier precautions (SSBP) in the surgical wards

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

catheter-related blood stream infection (CRBSI)

Key secondary outcomes

catheter-related infection (CRI)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

maximal sterile barrier precautions (MSBP)

Interventions/Control_2

standard sterile barrier precautions (SSBP)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

19 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who were admitted into the general surgical wards and were planed to be inserted a non-tunnel type CVC.

Key exclusion criteria

(1) Patients under 18 years old
(2) Patients who had a temparature 0f 38.1 degree centigrade or above.
(3) Patients who had already been administered antibiotics before CVC insertion.
(4) Patients who were inserted CVC as a replacement.
(5) Patients who were in the ICU.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshio Haga

Organization

National Hospital Organization Kumamoto Medical Center

Division name

Department of Surgery

Zip code


Address

1-5Ninomaru, Kumamoto, Japan

TEL

096-353-6501

Email

yoshio@kumamed.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshio Haga

Organization

National Hospital Organization Kumamoto Medical Center

Division name

Department of Surgery

Zip code


Address

1-5Ninomaru, Kumamoto, Japan

TEL

096-353-6501

Homepage URL


Email

yoshio@kumamed.jp


Sponsor or person

Institute

National Hospital Organization Kumamoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

Health Science Research Grants for Research on Medical Technology Assessment and Comprehensive Research on Aging and Health, from the Ministry of Health, Labour, and Welfare of Japan.

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 09 Month 27 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://journals.lww.com/annalsofsurgery/Abstract/2010/04000/Maximal_Sterile_Barrier_Precautions_Do_Not_Reduce.7.aspx

Number of participants that the trial has enrolled


Results

424 patients scheduled for CVC insertion in surgical units at nine medical centers in Japan were randomly assigned to either an MSBP group (n=211) or a standard sterile barrier precaution (SSBP) group (n=213). The median (range) duration of catheterization was 14 days (0 to 92 days) in the MSBP group and 14 days (0 to 112 days) in the SSBP group. There were 5 cases (2.4%) of CRBSI in the MSBP group and 6 cases (2.8%) in the SSBP group (relative risk [RR], 0.84; 95% confidence interval [CI], 0.26 to 2.7; P=0.77). The rate of CRBSIs per 1000 catheter days was 1.5 in the MSBP group and 1.6 in the SSBP group. There were 8 cases (3.8%) of catheter-related infections (CRIs) in the MSBP group and 7 cases (3.3%) in the SSBP group (RR, 1.2; 95%CI, 0.43 to 3.1; P=0.78). The rate of CRI per 1000 catheter days was 2.4 in the MSBP group and 1.9 in the SSBP group. This study is larger in sample size than the one performed by Raad et al and could not demonstrate better prevention of CRBSIs by MSBP compared with SSBP. A large RCT or at least a meta-analysis of any other studies in the literature is necessary to reach a conclusion on this issue.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2004 Year 07 Month 22 Day

Date of IRB


Anticipated trial start date

2004 Year 09 Month 01 Day

Last follow-up date

2006 Year 08 Month 01 Day

Date of closure to data entry

2006 Year 08 Month 01 Day

Date trial data considered complete

2008 Year 09 Month 01 Day

Date analysis concluded

2008 Year 09 Month 01 Day


Other

Other related information

This study was reported in Annals of Surgery.
Ann Surg, 2010;251(4): 620&#8211;623.


Management information

Registered date

2008 Year 09 Month 27 Day

Last modified on

2015 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001701


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name